Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy Zheng

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal for Immunotherapy of Cancer|May 20, 2021
Dichotomous and stable gamma delta T-cell number and function in healthy individualsLingling Ou, Huaishan Wang, Qin Liu, et al.
Developmental Cell|January 27, 2022
ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppressionWei Zhang, Wenqun Zhong, Beike Wang, et al.
Cancer Immunology Research|June 27, 2019
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor ControlEmilio Sanseviero, Erin M O'Brien, Jenna R Karras, et al.
Journal of the National Cancer Institute|April 16, 2020
Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving ImmunotherapyJahan J Mohiuddin, Brian Chu, Andrea Facciabene, et al.
Cell Reports|December 30, 2020
Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in CancerTaekyoung Kwak, Fang Wang, Hui Deng, et al.
Cell Reports|October 8, 2023
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunityWenqun Zhong, Youtao Lu, Xuexiang Han, et al.
Cancer Cell|October 11, 2022
Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapyEvgenii N Tcyganov, Emilio Sanseviero, Douglas Marvel, et al.
Molecular Cell|December 15, 2019
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in MelanomaMarie R Webster, Mitchell E Fane, Gretchen M Alicea, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2021
SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapyLova Sun, Sanjna Surya, Noah G Goodman, et al.
JCO Oncology Practice|June 16, 2021
SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed TherapyLova Sun, Sanjna Surya, Noah G Goodman, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal for Immunotherapy of Cancer|May 20, 2021
Dichotomous and stable gamma delta T-cell number and function in healthy individualsLingling Ou, Huaishan Wang, Qin Liu, et al.
Developmental Cell|January 27, 2022
ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppressionWei Zhang, Wenqun Zhong, Beike Wang, et al.
Cancer Immunology Research|June 27, 2019
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor ControlEmilio Sanseviero, Erin M O'Brien, Jenna R Karras, et al.
Journal of the National Cancer Institute|April 16, 2020
Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving ImmunotherapyJahan J Mohiuddin, Brian Chu, Andrea Facciabene, et al.
Cell Reports|December 30, 2020
Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in CancerTaekyoung Kwak, Fang Wang, Hui Deng, et al.
Cell Reports|October 8, 2023
Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunityWenqun Zhong, Youtao Lu, Xuexiang Han, et al.
Cancer Cell|October 11, 2022
Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapyEvgenii N Tcyganov, Emilio Sanseviero, Douglas Marvel, et al.
Molecular Cell|December 15, 2019
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in MelanomaMarie R Webster, Mitchell E Fane, Gretchen M Alicea, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2021
SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapyLova Sun, Sanjna Surya, Noah G Goodman, et al.
JCO Oncology Practice|June 16, 2021
SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed TherapyLova Sun, Sanjna Surya, Noah G Goodman, et al.
Pageof 2